This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins.

This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins.

This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins.

This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins.

Extract from the above information

Mainly acts on bronchial adrenergic receptors to relax smooth muscles

The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria.

The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria.

This product is a macrolide antibiotic, which has inhibitory effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has inhibitory effects on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. There is cross-resistance between this product and erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect.